Kore.ai, a global leader in enterprise AI, today announced the Kore.ai Agent Platform, an enterprise-grade multi-agent orchestration infrastructure for developing, deploying, and managing ...
Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback